- Login
- Register & Subscribe
- Sprache: EN FR DE
Regenerative Medicine
TiGenix raises €15.2 million to complete merger
Wednesday 1 June 2011
TiGenix NV of Belgium has raised €15.2 million in a rights issue, putting the finishing touches on a merger with Cellerix SA of Spain to create a new, larger company focused on cell-based therapeutics. The issue was fully subscribed.
Location
Belgium
Shire to buy regenerative medicine company
Tuesday 17 May 2011
Shire Plc has announced an agreement to acquire the privately-held US regenerative medicines company, Advanced BioHealing Inc, for $750 million in cash. The US company has a marketed product for diabetic foot ulcers.
Location
Ireland
Scientists report regeneration of eye tissue
Saturday 14 May 2011
Researchers from the Schepens Eye Research Institute in the US have reported regenerating retinal tissue in mice using induced pluripotent stem cells derived from mouse skin. The institute is an affiliate of the Harvard Medical School.
Location
United States
Takeda Ventures invests in Fate Therapeutics
Wednesday 11 May 2011
Takeda Ventures Inc, the corporate venture arm of Takeda Pharmaceutical Company, is the latest venture fund to invest in Fate Therapeutics Inc which is developing compounds that modulate stem-cell pathways. Financial details were not disclosed.
Location
United States
Dendreon to expand US production capacity
Tuesday 10 May 2011
Dendreon Corporation is seeking authorisation to open manufacturing sites at two new locations in the US for its prostate cancer vaccine, Provenge (sipuleucel-T), to meet demand for the treatment, David Urdal, CSO, told a London conference.
Location
United Kingdom
Geron to receive $25 million from CIRM
Thursday 5 May 2011
Geron Corp. is set to receive $25 million from the California Institute for Regenerative Medicine to support the clinical work on its stem-cell therapy for spinal cord injury. The money is a loan with repayment contingent on product success.
Location
United States
Cleveland Clinic spin-out reports on heart tissue repair
Tuesday 26 April 2011
Juventas Therapeutics, a 2007 spin-out of the Cleveland Clinic in the US, has reported the completion of a Phase 1 study of its regenerative medicine product for heart failure. No adverse events related to the treatment were reported.
Location
United States
Allogeneic cell therapy to be tested for stroke
Thursday 21 April 2011
The Stanford University School of Medicine, together with privately-held SanBio Inc, have started a Phase 1/2a trial of an allogeneic cell therapy on patients with stable deficits resulting from a stroke.
Location
United States
France’s Cellectis invests in iPS cells
Monday 11 April 2011
Cellectis SA of France has arranged financing for an ambitious project to produce induced pluripotent stem cells (iPS) on an industrial scale so that they can be used for a range of commercial applications, including the production of red blood cells.
Location
France
Tissue-engineered urethras reported functional for up to six years
Sunday 3 April 2011
Patients who received tissue-engineered implants to correct for defects in their urethras reported normal functioning of their urethras for up to six years after surgery, according to an observational study in The Lancet.
Location
United Kingdom
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013